• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗜麦芽窄食单胞菌的抗生素敏感性及其与临床管理的关系。

The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.

作者信息

Smit W J, Boquest A L, Geddes J E, Tosolini F A

机构信息

Department of Medical Microbiology, Austin Hospital, Heidelberg, Victoria.

出版信息

Pathology. 1994 Jul;26(3):321-4. doi: 10.1080/00313029400169751.

DOI:10.1080/00313029400169751
PMID:7991292
Abstract

An increase in recovery of Xanthomonas maltophilia from clinical specimens at our institutions prompted, amongst other measures, an investigation of the antibiotic susceptibility patterns of the organism. Fifty-five consecutive first isolates of Xanthomonas maltophilia were obtained and antimicrobial susceptibility tests were carried out by the agar dilution method. Trimethoprim/sulfamethoxazole was the most active antimicrobial agent (94% susceptible), with 71% susceptible to ticarcillin/clavulanic acid, 56% susceptible to ciprofloxacin and 49% susceptible to ceftazidime. Amoxycillin/clavulanic acid and imipenem were inactive (0% susceptible), while aminoglycosides were effective against only 7% of isolates. Potentiation was observed with both the combination of trimethoprim and sulfamethoxazole and the combination of ticarcillin and clavulanic acid. Familiarity with the antibiotic susceptibility pattern of Xanthomonas maltophilia as well as the potential shortcomings of the in vitro susceptibility data are important in the effective clinical management of Xanthomonas maltophilia infections.

摘要

在我们机构中,嗜麦芽窄食单胞菌从临床标本中的分离率有所增加,这促使我们采取了一系列措施,其中包括对该菌的抗生素敏感性模式进行调查。我们获取了55株连续的嗜麦芽窄食单胞菌初分离株,并采用琼脂稀释法进行了抗菌药物敏感性试验。甲氧苄啶/磺胺甲恶唑是最有效的抗菌药物(94%敏感),71%对替卡西林/克拉维酸敏感,56%对环丙沙星敏感,49%对头孢他啶敏感。阿莫西林/克拉维酸和亚胺培南无活性(0%敏感),而氨基糖苷类仅对7%的分离株有效。甲氧苄啶和磺胺甲恶唑的组合以及替卡西林和克拉维酸的组合均观察到增效作用。熟悉嗜麦芽窄食单胞菌的抗生素敏感性模式以及体外敏感性数据的潜在缺点,对于嗜麦芽窄食单胞菌感染的有效临床管理至关重要。

相似文献

1
The antibiotic susceptibilities of Xanthomonas maltophilia and their relation to clinical management.嗜麦芽窄食单胞菌的抗生素敏感性及其与临床管理的关系。
Pathology. 1994 Jul;26(3):321-4. doi: 10.1080/00313029400169751.
2
A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy.嗜麦芽窄食单胞菌对抗菌药物敏感性的变化模式:对治疗的启示
Antimicrob Agents Chemother. 1994 Mar;38(3):624-7. doi: 10.1128/AAC.38.3.624.
3
In vitro susceptibility of 124 Xanthomonas maltophilia (Stenotrophomonas maltophilia) isolates: comparison of the agar dilution method with the E-test and two agar diffusion methods.124株嗜麦芽窄食单胞菌(嗜麦芽寡养单胞菌)的体外药敏试验:琼脂稀释法与E试验及两种琼脂扩散法的比较
APMIS. 1996 Feb;104(2):108-14.
4
Stenotrophomonas maltophilia: emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model.嗜麦芽窄食单胞菌:治疗期间及体外药效学腔室模型中多重耐药菌株的出现
Antimicrob Agents Chemother. 1996 Dec;40(12):2859-64. doi: 10.1128/AAC.40.12.2859.
5
In vitro activities of antimicrobial combinations against Stenotrophomonas (Xanthomonas) maltophilia.抗菌药物组合对嗜麦芽窄食单胞菌(嗜麦芽黄单胞菌)的体外活性。
Antimicrob Agents Chemother. 1995 Oct;39(10):2220-3. doi: 10.1128/AAC.39.10.2220.
6
Antibiotic susceptibility profile of Xanthomonas maltophilia. In vitro activity of beta-lactam/beta-lactamase inhibitor combinations.嗜麦芽窄食单胞菌的抗生素敏感性概况。β-内酰胺/β-内酰胺酶抑制剂联合用药的体外活性。
Diagn Microbiol Infect Dis. 1991 May-Jun;14(3):239-43. doi: 10.1016/0732-8893(91)90038-h.
7
In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia. Inconsistent correlation of agar dilution and of disk diffusion test results.
Diagn Microbiol Infect Dis. 1991 Sep-Oct;14(5):447-50. doi: 10.1016/0732-8893(91)90072-n.
8
Susceptibilities of 97 strains of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors.97株嗜麦芽窄食单胞菌对抗生素的敏感性及β-内酰胺酶抑制剂的作用
Microbios. 1997;91(367):97-103.
9
Comparison of E test and agar dilution for antimicrobial susceptibility testing of Stenotrophomonas (Xanthomonas) maltophilia.嗜麦芽窄食单胞菌(嗜麦芽黄单胞菌)抗菌药敏试验中E试验与琼脂稀释法的比较。
J Clin Microbiol. 1995 May;33(5):1428-30. doi: 10.1128/jcm.33.5.1428-1430.1995.
10
Antibiotic susceptibility of Stenotrophomonas (Xanthomonas) maltophilia: comparative (NCCLS criteria) evaluation of antimicrobial drugs with the agar dilution and the agar disk diffusion (Bauer-Kirby) tests.嗜麦芽窄食单胞菌(黄单胞菌属)的抗生素敏感性:采用琼脂稀释法和琼脂纸片扩散法(鲍-基二氏法),依据美国国家临床实验室标准委员会(NCCLS)标准对抗菌药物进行比较评估
Chemotherapy. 1998 May-Jun;44(3):164-73. doi: 10.1159/000007111.

引用本文的文献

1
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.对甲氧苄啶-磺胺甲恶唑耐药的嗜麦芽窄食单胞菌:一个日益严重的问题。
Ann Clin Microbiol Antimicrob. 2006 Sep 18;5:23. doi: 10.1186/1476-0711-5-23.
2
Novel nosocomial infections by Stenotrophomonas maltophilia: first reported case from Lucknow, North India.嗜麦芽窄食单胞菌引起的新型医院感染:印度北部勒克瑙的首例报告病例。
J Clin Microbiol. 2003 Aug;41(8):3989-90. doi: 10.1128/JCM.41.8.3989-3990.2003.
3
Occurrence of variants with temperature-dependent susceptibility (TDS) to antibiotics among Stenotrophomonas maltophilia clinical strains.
嗜麦芽窄食单胞菌临床菌株中存在对抗生素具有温度依赖性敏感性(TDS)的变体。
Folia Microbiol (Praha). 2001;46(2):151-5. doi: 10.1007/BF02873595.
4
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌相关感染的微生物学及临床方面
Clin Microbiol Rev. 1998 Jan;11(1):57-80. doi: 10.1128/CMR.11.1.57.
5
In vitro activities of beta-lactam-beta-lactamase inhibitor combinations against Stenotrophomonas maltophilia: correlation between methods for testing inhibitory activity, time-kill curves, and bactericidal activity.β-内酰胺-β-内酰胺酶抑制剂组合对嗜麦芽窄食单胞菌的体外活性:抑制活性检测方法、时间-杀菌曲线与杀菌活性之间的相关性
Antimicrob Agents Chemother. 1997 Dec;41(12):2612-5. doi: 10.1128/AAC.41.12.2612.
6
Multiple antibiotic resistance in Stenotrophomonas maltophilia.嗜麦芽窄食单胞菌的多重抗生素耐药性
Antimicrob Agents Chemother. 1997 May;41(5):1140-2. doi: 10.1128/AAC.41.5.1140.
7
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infections.亚胺培南/西司他丁:其抗菌活性、药代动力学及治疗严重感染疗效的最新进展
Drugs. 1996 Jan;51(1):99-136. doi: 10.2165/00003495-199651010-00008.